Y. Mino

发表

Changes in CD14 expression on monocytes and changes in serum soluble CD14 level during hemodialysis

H. Makino, Y. Nagake, H. Yamasaki, 2000, Clinical and Experimental Nephrology.

Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system.

T. Naito, K. Ohnishi, J. Kawakami, 2012, Drug metabolism and pharmacokinetics.

Pharmacokinetic variability of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in remission maintenance phase.

K. Shimoyama, N. Ogawa, T. Naito, 2011, Biological & pharmaceutical bulletin.

Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase

Y. Kagawa, T. Naito, T. Takayama, 2011, Journal of clinical pharmacy and therapeutics.

Saturated Metabolism of Voriconazole N-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses.

Takahiro Yamada, T. Naito, J. Kawakami, 2015, Biological & pharmaceutical bulletin.

Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.

H. Yamada, Takahiro Yamada, T. Naito, 2013, Clinica chimica acta; international journal of clinical chemistry.

Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission‐maintenance phase

K. Shimoyama, N. Ogawa, T. Naito, 2012, Journal of clinical pharmacy and therapeutics.

Comparison of Pharmacokinetics of Mycophenolic Acid and Its Glucuronide Between Patients With Lupus Nephritis and With Kidney Transplantation

A. Hishida, Y. Kagawa, T. Naito, 2008, Therapeutic drug monitoring.

Mycophenolic acid exposure and complement fraction C3 influence inosine 5′-monophosphate dehydrogenase activity in systemic lupus erythematosus

K. Shimoyama, N. Ogawa, T. Naito, 2017, Annals of clinical biochemistry.

Interindividual variations in aprepitant plasma pharmacokinetics in cancer patients receiving cisplatin-based chemotherapy for the first time.

T. Naito, S. Hosokawa, H. Furuse, 2013, Biological & pharmaceutical bulletin.

Validated LC coupled to ESI‐MS/MS analysis for fentanyl in human plasma and UV analysis in applied reservoir transdermal patches using a simple and rapid procedure

Y. Kagawa, T. Naito, J. Kawakami, 2009, Journal of clinical pharmacy and therapeutics.

Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.

Y. Kagawa, T. Naito, A. Otsuka, 2009, Clinica chimica acta; international journal of clinical chemistry.

Stereoselective interaction of tolvaptan with amiodarone under racemic metabolic impact by CYP3A5 genotypes in heart failure patients

M. Saotome, T. Naito, J. Kawakami, 2022, European Journal of Clinical Pharmacology.

Impact of concentrative nucleoside transporter 1 gene polymorphism on oral bioavailability of mizoribine in stable kidney transplant recipients.

Y. Kagawa, T. Naito, A. Otsuka, 2009, Basic & clinical pharmacology & toxicology.

Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.

Takahiro Yamada, T. Naito, J. Kawakami, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Impact of inflammation and concomitant glucocorticoid administration on plasma concentration of triazole antifungals in immunocompromised patients.

Takahiro Yamada, T. Naito, J. Kawakami, 2015, Clinica chimica acta; international journal of clinical chemistry.

Rapid simultaneous determination of voriconazole and its N-oxide in human plasma using an isocratic high-performance liquid chromatography method and its clinical application.

Takahiro Yamada, T. Naito, J. Kawakami, 2012, Clinical biochemistry.

Simultaneous determination of itraconazole and its CYP3A4-mediated metabolites including N-desalkyl itraconazole in human plasma using liquid chromatography-tandem mass spectrometry and its clinical application

T. Naito, T. Ono, J. Kawakami, 2020, Journal of Pharmaceutical Health Care and Sciences.

Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan

T. Naito, J. Kawakami, Y. Mino, 2022, Pharmacy in practice.

Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application

K. Umemura, T. Naito, J. Kawakami, 2012, Journal of clinical pharmacy and therapeutics.

Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.

Y. Kagawa, T. Naito, J. Kawakami, 2008, Journal of pharmaceutical and biomedical analysis.

Impact of Calcineurin Inhibitors on Urinary Excretion of Mycophenolic Acid and Its Glucuronide in Kidney Transplant Recipients

Y. Kagawa, T. Naito, Toshiki Ito, 2009, Journal of clinical pharmacology.

Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects.

K. Umemura, T. Naito, J. Kawakami, 2012, Drug metabolism and pharmacokinetics.

Suitability of chemiluminescent enzyme immunoassay for the measurement of blood tacrolimus concentrations in rheumatoid arthritis.

K. Hirano, T. Naito, J. Kawakami, 2011, Clinical biochemistry.

ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis.

K. Hirano, K. Shimoyama, N. Ogawa, 2015, Clinica chimica acta; international journal of clinical chemistry.

Impact of CYP3A5 genetic polymorphism on cross-reactivity in tacrolimus chemiluminescent immunoassay in kidney transplant recipients.

K. Hirano, T. Naito, T. Takayama, 2012, Clinica chimica acta; international journal of clinical chemistry.

Validated determination method of tramadol and its desmethylates in human plasma using an isocratic LC-MS/MS and its clinical application to patients with cancer pain or non-cancer pain

T. Naito, J. Kawakami, Y. Mino, 2016, Journal of Pharmaceutical Health Care and Sciences.

Validated determination method of tramadol and its desmethylates in human plasma using an isocratic LC-MS/MS and its clinical application to patients with cancer pain or non-cancer pain

T. Naito, J. Kawakami, Y. Mino, 2016, Journal of pharmaceutical health care and sciences.

Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.

Y. Kagawa, T. Naito, A. Otsuka, 2009, Clinical biochemistry.

Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients.

Y. Kagawa, T. Naito, A. Otsuka, 2008, Biological & pharmaceutical bulletin.

[Assay of GBM antigen in urine and serum with an anti-human renal monoclonal antibody].

Y. Mino, 1990, Nihon Jinzo Gakkai shi.

Blood distribution of bortezomib and its kinetics in multiple myeloma patients.

T. Naito, K. Ohnishi, T. Ōsawa, 2014, Clinical biochemistry.

Maintenance therapy with erythropoietin for renal anemia

H. Makino, T. Ogura, Z. Ota, 1994 .

Improvement of anemia by erythropoietin and changes in hemodialysis efficiency

T. Ogura, Z. Ota, M. Hiramatsu, 1994 .

Impact of Calcineurin Inhibitors on Urinary Excretion of Mycophenolic Acid and Its Glucuronide in Kidney Transplant Recipients

Y. Kagawa, T. Naito, Toshiki Ito, 2009, Journal of clinical pharmacology.

A study on cross-reactivity of anti-DNA antibody with glycosaminoglycans.

N. Kashihara, H. Makino, Z. Ota, 1993, Acta medica Okayama.